Posted in | News | Consumer Robotics

Intellitronix Announces Patent Filing for Weapons Detection Robot

Intellitronix, a wholly-owned subsidiary of US Lighting Group, today announced that it has filed a patent for a weapons detecting robot utilizing the Promobot LLC robot.

“Intellitronix sees weapons detection as a growing market, especially in schools,” said Intellitronix CEO, Paul Spivak. “As a father, I cannot do enough to make schools a safe environment for children and as a Company, Intellitronix is advancing that effort through our software collaboration efforts that utilizes the Promobot LLCs robot which our company holds the exclusive marketing rights in the United States.”

According to a CNN news article, the US has had 57 times as many school shootings as the other major industrialized nations combined.  Since 2009, there has been 288 school shooting in the U.S.  So far this year, there has been an average of one shooting per week and while gun control advocates say curbing firearms ownership will help, Intellitronix believes weapons detection is at the forefront of curbing shootings – both in schools as well as other commercial applications.

Promobot currently does promotions and sales. It uses artificial intelligence to determine differences between men and women, age range, and has the capability of facial recognition up to 5,000 people. Its responses are customizable as well. Based on the current success of Promobot’s features, Intellitronix is now working on pattern recognition and inferred scanning technology to help its weapon detection endeavor.  

Source: https://www.intellitronix.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.